Quantinuum
jointly validated a Generative Quantum AI (GenQAI) framework for pharmaceutical R&D with NVIDIA and Pfizer in 2026, with researchers developing ADAPT-GQE to accelerate quantum-circuit creation for complex molecular models.
- Country
- United Kingdom
EU
Coverage
| EU | US | |
|---|---|---|
| digital-it | ✓ | ✓ |
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Quantum computing for molecular modeling | digital-it | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.